KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Invested Capital: 2009-2025

Historic Invested Capital for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Invested Capital fell 21.61% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 21.61%. This contributed to the annual value of $596.8 million for FY2024, which is 4.06% down from last year.
  • Per Dynavax Technologies' latest filing, its Invested Capital stood at $534.1 million for Q3 2025, which was up 8.09% from $494.2 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Invested Capital peaked at $681.4 million during Q3 2024, and registered a low of $67.6 million during Q3 2021.
  • Moreover, its 3-year median value for Invested Capital was $596.8 million (2024), whereas its average is $587.9 million.
  • As far as peak fluctuations go, Dynavax Technologies' Invested Capital surged by 743.72% in 2021, and later fell by 23.13% in 2025.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Invested Capital stood at $222.4 million in 2021, then spiked by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then decreased by 4.06% to $596.8 million in 2024, then declined by 21.61% to $534.1 million in 2025.
  • Its Invested Capital was $534.1 million in Q3 2025, compared to $494.2 million in Q2 2025 and $530.9 million in Q1 2025.